Selection and perception of methotrexate treatment information in people with rheumatoid arthritis

Autor: Nieves Leonardo, Christopher Hill, Rachelle Buchbinder, Michelle A. Graham, Samuel L Whittle, Susan C. Lester, Debra Rowett, Claire Barrett
Přispěvatelé: Leonardo, Nieves, Lester, Susan, Graham, Michelle, Barett, Claire, Whittle, Samuel, Rowett, Debra, Buchbinder, Rachelle, Hill, Catherine L
Rok vydání: 2020
Předmět:
musculoskeletal diseases
rheumatoid arthritis
Male
medicine.medical_specialty
Time Factors
media_common.quotation_subject
Computer-assisted web interviewing
Arthritis
Rheumatoid
03 medical and health sciences
0302 clinical medicine
Rheumatology
immune system diseases
Interquartile range
Surveys and Questionnaires
Perception
medicine
Humans
In patient
030212 general & internal medicine
skin and connective tissue diseases
Retrospective Studies
media_common
030203 arthritis & rheumatology
Methotrexate treatment
business.industry
Negative information
drug treatment
treatment opinion
Middle Aged
medicine.disease
Methotrexate
Treatment Outcome
Patient perceptions
Antirheumatic Agents
Family medicine
Rheumatoid arthritis
methotrexate treatment
Hospital Information Systems
Female
business
methotrexate in rheumatoid arthritis
Follow-Up Studies
Zdroj: International Journal of Rheumatic Diseases. 23:805-812
ISSN: 1756-185X
1756-1841
DOI: 10.1111/1756-185x.13833
Popis: Objective: To determine beliefs about methotrexate (MTX) in patients with rheumatoid arthritis (RA) in relation to utilized information sources.Methods: RA patients, who were current participants in the Australian national biologic registry, completed an online questionnaire regarding their use and views about MTX (N = 1010). Participants who used MTX were asked about which MTX information sources they consulted, and whether positive or negative views were obtained.The Beliefs about Medicine Questionnaire (BMQ), was used to measure patient beliefs about MTX. Results: The survey response rate was 804/1010 (80%). MTX survey data were analyzed for 742 RA participants (mean age 59 years, 76% female, mean disease duration 19 years) who had used MTX, with 494/742 (67%) reporting current use.Participants consulted multiple information sources (median 3, interquartile range 1-5). Rheumatologists (98%), general practitioners (GPs) (55%), internet searches(39%), educational websites (38%), and pharmacists (37%) were the most common information sources utilized. Positive MTX information was most often obtained from rheumatologists (92%), GPs (66%), and educational websites (56%). Negative information was most often obtained from relatives, social media, internet chat rooms and friends. Information from rheumatologists was the most influential on favorable BMQ MTX-specific scores, whereas information from educational websites also affirmed the need for MTX. Conclusion: RA patients have significant concerns regarding MTX and consult a variety of sources for MTX information. However, the patient perception of this information varies widely. Rheumatologists and educational websites are the most important information sources in terms of a positive influence on the patient's perception of MTX. Refereed/Peer-reviewed
Databáze: OpenAIRE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje